Daniel J. Flores

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans

Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends et al. · Science Translational Medicine · 2022 · 215 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults

Yíngyún Caì, Seme Diallo, Kim Rosenthal et al. · Science Translational Medicine · 2024 · 29 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Inhibition of Curcumin-Treated Herpes Simplex Virus 1 and 2 in Vero Cells

Daniel J. Flores, Lee H. Lee, Sandra D. Adams · Advances in Microbiology · 2016 · 28 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

1355. The SARS-CoV-2 Monoclonal Antibody AZD3152 Potently Neutralizes Historical and Emerging Variants and is Being Developed for the Prevention and Treatment of COVID-19 in High-risk Individuals

Joseph R. Francica, Cai Yingyun, Seme Diallo et al. · Open Forum Infectious Diseases · 2023 · 13 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans

Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends et al. · medRxiv · 2021 · 12 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14